| Line Item | 2025-10-26 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $57.01B | +22.0% | +62.5% |
| Cost of Revenue | $15.16B | +17.6% | +69.8% |
| Gross Profit | $41.85B | +23.6% | +60.0% |
| R&D Expense | $4.71B | +9.6% | +38.8% |
| SG&A Expense | $1.13B | +1.1% | +26.4% |
| Operating Income | $36.01B | +26.6% | +64.7% |
| Pre-tax Income | $37.94B |
| Line Item | 2025-10-26 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.49B | -1.3% | +26.1% |
| Short-term Investments | $49.12B | +8.8% | +67.2% |
| Accounts Receivable | $33.39B | +20.1% | +88.7% |
| Inventory | $19.78B | +32.2% | +158.5% |
| Current Assets | $116.49B | +14.0% | +72.2% |
| Total Assets |
| Line Item | 2025-10-26 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $66.53B | — | — |
| Investing Cash Flow | -$21.37B | — | — |
| Financing Cash Flow | -$42.27B | — | — |
| +21.6% |
| +70.0% |
| Income Tax | $6.03B | +26.0% | +100.4% |
| Net Income | $31.91B | +20.8% | +65.3% |
| EPS (Basic) | $1.31 | +21.3% | +65.8% |
| EPS (Diluted) | $1.30 | +20.4% | +66.7% |
| $161.15B |
| +14.5% |
| +67.8% |
| Current Liabilities | $26.07B | +7.5% | +58.2% |
| Long-term Debt | $8.47B | +0.0% | +0.1% |
| Total Liabilities | $42.25B | +4.0% | +40.3% |
| Stockholders' Equity | $118.90B | +18.7% | +80.4% |